News | December 03, 2008

EchoCRT Trial Enrolls First Europeans to Investigate Resynchronization in Heart Failure Patients

December 4, 2008 - BIOTRONIK said this week the first European patients have been enrolled into the EchoCRT (Echocardiography guided Cardiac Resynchronization Therapy) trial by the team of physicians at Hospital Clinic in Barcelona, Spain.

The trial will be led by Professor Josep Brugada, M.D., director of the Thorax Institute, chairman of the cardiology department, EchoCRT Executive Committee member and president of the European Heart Rhythm Association. The EchoCRT trial is the largest prospective, randomized, double-blind, international, multicenter clinical trial of its kind. It is designed to demonstrate that optimal medical therapy plus CRT reduces all-cause mortality or first hospitalization for worsening heart failure in the study population compared to optimal medical therapy alone. Eligible patients must have echocardiographic evidence of left ventricular dyssynchrony (discoordinated pumping action of the heart) with a “narrow QRS” width (

Worldwide 125 sites will participate in EchoCRT and 80 of these sites are located in Europe and Australia. Overall, it is planned that 700 of the target 1,258 patients to be randomized to the study will be recruited from European sites in Austria, Belgium, Czech Republic, Denmark, France, Germany, Netherlands, Spain, Switzerland and the U.K.

Cardiac resynchronization therapy (CRT) is a proven, life-saving, device-based treatment for certain heart failure patients with ventricular dyssynchrony. Patients enrolled in the EchoCRT study are implanted with the Lumax HF-T CRT-D device. The maker said these new cardiac devices are equipped with pioneering features, such as BIOTRONIK Home Monitoring, providing the physician with automatic, remote updates on their patient’s cardiovascular and device status.

“EchoCRT will answer important questions about device-based treatment for hundreds of thousands of heart failure patients,” said Professor Frank Ruschitzka, M.D., University of Zürich, Executive Committee co-chairman and international co-principal investigator for EchoCRT. “We are looking forward to the results of EchoCRT to know whether the majority of heart failure patients can also benefit from device-based therapy.”

EchoCRT is an investigator clinical trial led by the University of Zürich. GE echocardiography equipment will be utilized throughout EchoCRT and GE, as a clinical cooperation partner to BIOTRONIK in this study, will provide training and technical support in order to reduce data variability and ensure optimal reliability of outcomes. BIOTRONIK is the sole sponsor of the EchoCRT study being conducted under an investigational device exemption (IDE) granted by the FDA.

For more information:

Related Content

Mexican Doctors Safely Reuse Donated Pacemakers After Sterilization

Mexican government reports conclude more than half of the population does not have access to social security or private insurance that covers a pacemaker implant, and 44 percent live in poverty. Recycling donated, explanted pacemakers offers a new option for these patients.

News | Pacemakers| November 10, 2017
Mexican doctors have safely reused donated pacemakers after sterilization, shows a study presented at the 30th Mexican...
Pacemakers and Other Cardiac Devices Can Help Solve Forensic Cases
News | Pacemakers| June 20, 2017
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the European...
Videos | Pacemakers| May 23, 2017
Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospita
micra leadless pacemaker
Feature | Pacemakers| May 16, 2017
May 16, 2017 - The preliminary results for the Medtronic Micra Transcatheter Pacing System (TPS) Post-Approval Regist
Videos | Pacemakers| May 16, 2017
This video, provided by Medtronic, demonstrates the implantation of Micra transcatheter pacing system (TPS).
closed loop stimulation, DDD-CLS, ACC17, SPAIN trial
Feature | Pacemakers| March 22, 2017
March 22, 2017 — Patients with recurrent fainting episodes (syncope) who received a pacemaker delivering a pacing pro
Micra leadless pacemaker, CMS, medicare reimbursement
News | Pacemakers| March 10, 2017
March, 10, 2017 - Medtronic announced that the U.S.
Medtronic, Micra TPS pacemaker, transcatheter pacing system, global clinical trial, one-year results, ESC 2016
News | Pacemakers| August 29, 2016
August 29, 2016 — Medtronic plc announced new long-term results from the Medtronic Micra Transcatheter Pacing System
Medtronic, Micra TPS pacemaker, Global Clinical Trial, Cardiostim 2016
News | Pacemakers| June 09, 2016
Medtronic plc announced new results from the Medtronic Micra Transcatheter Pacing System (TPS) Global Clinical Trial in...
Medtronic, Micra TPS, transcatheter pacing system, pacemaker, Jersey Shore University Medical Center, New Jersey first
News | Pacemakers| June 06, 2016
Jersey Shore University Medical Center, part of Meridian CardioVascular Network, is the first hospital in New Jersey to...
Overlay Init